Nexilico is an early-stage startup developing predictive computational platforms for gut microbiome precision medicine.
Nexilico, Inc. is an early-stage startup with the mission to advance microbiome and precision medicine research and development by developing next generation of predictive, computational platforms that improve drug design and development as well as therapeutics clinical outcome.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 22, 2020 | Grant | $225K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |